SBIR/STTR Research Award
Novel Broad/Narrow-Spectrum Antibiotics Against Bacteria
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Mycosynthetix, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JEPXCJLSMLS3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): This application addresses the need for NEW THERAPEUTICS, specifically 1. narrow spectrum antibiotics 2. broad spectrum antibiotics This will be accomplished by directing the efforts of a SUCCESSFUL ANTIMICR
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Fungal Metabolites Fuel Drug Discovery for Pathogenic Free-Living Amoebae
- Fungal Metabolites as Novel Anthelmintics against Soil-Transmitted Helminthes.
- Production of the organic herbicide Mevalocidin by fungi
- New Tuberculosis Antibiotics from Filamentous Fungi
Research funding history
5 SBIR/STTR records share this UEI (2004–2016). Reported award amounts total $802,392. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, Department of Agriculture